skip to main content
10.1145/3502803.3502810acmotherconferencesArticle/Chapter ViewAbstractPublication PagesicbspConference Proceedingsconference-collections
research-article

NF90 regulates HIF-1/VEGF expression through PI3K/Akt/mTOR pathway to promote angiogenesis in NSCLC

Authors Info & Claims
Published:31 January 2022Publication History

ABSTRACT

As one of the most diagnosed cancers in the world and the main cause for global cancer mortality, the treatment and prognosis of NSCLC is still a challenge. Some studies find that NF90, a double-stranded RNA binding protein, can regulate the expression of VEGF and further inhibit tumor angiogenesis and tumor growth in breast cancer and cervical cancer. In this article, experiments are designed to explore the correlation between NF90 and VEGF/HIF-1 in NSCLC through using siRNA to knock down NF90 in lung cancer cells and observing VEGF/HIF-1 expression by western blot and ELISA. Use Transwell assay and tube formation assay to detect the tube formation and cell migration of HUVECs in vitro while observe the tumor growth in vivo through Xenograft. Experiments also involve the exploration of PI3K/Akt/mTOR cellular pathway. The results supporting the hypothesis would indicate that NF90 is possibly a new anti-angiogenesis target for NSCLC treatment. And further study can explore the more specific mechanisms for the cooperation between NF90 and VEGF/HIF-1 and develop the novel targeted drugs for NSCLC.

References

  1. Clinton SK, Giovannucci EL, Hursting SD. The World Cancer Research Fund/American Institute for Cancer Research Third Expert Report on Diet, Nutrition, Physical Activity, and Cancer: Impact and Future Directions. J Nutr. 2020;150(4):663-71.Google ScholarGoogle Scholar
  2. Jiang W, Huang H, Ding L, Zhu P, Saiyin H, Ji G, Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability. Oncogene. 2015;34(34):4460-70.Google ScholarGoogle Scholar
  3. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29(5):625-34.Google ScholarGoogle Scholar
  4. Vumbaca F, Phoenix KN, Rodriguez-Pinto D, Han DK, Claffey KP. Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol Cell Biol. 2008;28(2):772-83.Google ScholarGoogle Scholar
  5. Sarris EG, Saif MW, Syrigos KN. The Biological Role of PI3K Pathway in Lung Cancer. Pharmaceuticals (Basel). 2012;5(11):1236-64.Google ScholarGoogle Scholar
  6. Zhang W, Xiong Z, Wei T, Li Q, Tan Y, Ling L, Nuclear factor 90 promotes angiogenesis by regulating HIF-1alpha/VEGF-A expression through the PI3K/Akt signaling pathway in human cervical cancer. Cell Death Dis. 2018;9(3):276.Google ScholarGoogle Scholar
  7. Liang L, Hui K, Hu C, Wen Y, Yang S, Zhu P, Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells. J Exp Clin Cancer Res. 2019;38(1):71.Google ScholarGoogle Scholar
  8. Karar J, Maity A. PI3K/AKT/mTOR Pathway in Angiogenesis. Front Mol Neurosci. 2011; 4:51.Google ScholarGoogle Scholar
  9. Zhang C, Xie C, Wang X, Huang Y, Gao S, Lu J, Aberrant USP11 expression regulates NF90 to promote proliferation and metastasis in hepatocellular carcinoma. Am J Cancer Res. 2020;10(5):1416-28.Google ScholarGoogle Scholar
  10. Guo NL, Wan YW, Tosun K, Lin H, Msiska Z, Flynn DC, Confirmation of gene expression-based prediction of survival in non-small cell lung cancer. Clin Cancer Res. 2008;14(24):8213-20.Google ScholarGoogle Scholar
  11. Piperdi B, Merla A, Perez-Soler R. Targeting angiogenesis in squamous non-small cell lung cancer. Drugs. 2014;74(4):403-13.Google ScholarGoogle Scholar
  12. Alevizakos M, Kaltsas S, Syrigos KN. The VEGF pathway in lung cancer. Cancer Chemother Pharmacol. 2013;72(6):1169-81.Google ScholarGoogle Scholar

Recommendations

Comments

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Sign in
  • Published in

    cover image ACM Other conferences
    ICBSP '21: Proceedings of the 2021 6th International Conference on Biomedical Imaging, Signal Processing
    October 2021
    67 pages
    ISBN:9781450385817
    DOI:10.1145/3502803

    Copyright © 2021 ACM

    Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]

    Publisher

    Association for Computing Machinery

    New York, NY, United States

    Publication History

    • Published: 31 January 2022

    Permissions

    Request permissions about this article.

    Request Permissions

    Check for updates

    Qualifiers

    • research-article
    • Research
    • Refereed limited
  • Article Metrics

    • Downloads (Last 12 months)9
    • Downloads (Last 6 weeks)0

    Other Metrics

PDF Format

View or Download as a PDF file.

PDF

eReader

View online with eReader.

eReader

HTML Format

View this article in HTML Format .

View HTML Format